ArticleiScience2025
Dual-channel deep learning captures intratumoural heterogeneity on CECT for preoperative risk stratification of thymic epithelial tumors.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiomics: Current Applications and Future Directions.MedComm · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate preoperative risk stratification is critical for treating thymic epithelial tumors (TETs). This study developed a deep learning framework that combines a dual-channel convolutional neural network (CNN) with an adaptive dynamic clustering algorithm. The model was trained on contrast-enhanced CT (CECT) images from 336 multicenter TET patients. It first automates the segmentation of tumor subregions. Then, it constructs dual-channel input data containing the largest cross-sectional ROI and its corresponding habitat masks. Using transfer learning, we trained four CNN architectures for risk stratification. The DenseNet121-based dual-channel CNN achieved an AUC of 0.74-0.76 on an external test set. This performance surpassed conventional radiomics, single-channel CNN, and radiologists' visual assessment. Our framework effectively captures intratumoral heterogeneity, improves risk stratification accuracy, and aids in rapid identification of high-risk patients. This approach can support personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.